More than Just a Meeting
As the Muscular Disorders Community reunites under one roof to learn, collaborate, and celebrate the frenzied success and growth of the field, make sure to take part and enjoy the variety of structured networking opportunities beyond the scientific presentations, including:
Scientific Poster Session
Scientific Program Day One | Wednesday, January 27 | 2:30 – 3:15pm
Share your research, showcase your scientific approach, and connect with fellow experts advancing therapies for muscular disorders. This dedicated networking session is designed to facilitate knowledge exchange across preclinical, translational, and clinical development, with discussions spanning key industry challenges including biodistribution, muscle-targeted delivery, efficacy assessment, toxicity evaluation, and model selection.
Why Participate?
- Showcase your work to leaders in muscular disorder drug development
- Gain feedback on your research, strategy, or therapeutic approach
- Learn from peers across preclinical, translational, and clinical programs
- Build valuable connections within the neuromuscular and muscular dystrophy community
Submit Abstract for approval: Click here to submit
Submission Deadline: please submit abstract for approval by Monday, January 18
*Please note, posters should not be used for sales and marketing purposes, and vendor delegates will not be permitted to submit. All abstracts are subject to approval by the conference organizers.
Speed Networking
Scientific Program Day One | Wednesday, January 27 | 10:30 – 11:30am
Join our dedicated speed networking session designed for professionals advancing therapies for muscular dystrophies and related neuromuscular disorders. Connect with fellow drug developers, translational scientists, clinical leaders, and technology innovators through a series of focused conversations designed to spark new ideas, share experiences, and build valuable industry relationships.
Muscular Innovation Exchange
Scientific Program Day Two | Thursday, January 28 | 10:30 – 11am
Join the discussion most relevant to your work and gain insights from experts tackling shared translational and clinical development challenges. Move between therapeutic area-focused discussion tables throughout the session to connect with peers across muscular dystrophies and neuromuscular disorders, exchange practical experiences, and uncover new approaches to advancing drug development. Designed to facilitate meaningful conversations and valuable industry connections, this interactive forum offers a unique opportunity to learn directly from those navigating similar scientific, regulatory, and clinical hurdles.
Roundtable & Panel Discussions
Join expert-led roundtable discussions and panel debates designed to encourage open dialogue, audience participation, and peer-to-peer learning. Engage directly with leaders from biotech, pharma, and patient-focused organizations as they discuss key topics including clinical endpoints, patient heterogeneity, biomarker development, target discovery, and emerging therapeutic modalities. These collaborative sessions provide an ideal environment to ask questions, benchmark strategies, share experiences, and connect with fellow stakeholders shaping the future of muscular disorder drug development.
Day One Clinical Endpoints Roundtable: Evaluating the future of clinical endpoints by balancing statistical significance with meaningful patient outcomes.
Day One Therapeutic Modalities Pharma Panel: Comparing the opportunities and limitations of genetic, stem cell, small molecule, and RNA-based approaches for muscle diseases.
Day Two Target Discovery Roundtable: Exploring how lessons from non-muscular disease areas can uncover novel targets and address unmet patient needs.
Workshop Sessions
Pre-Conference Day | Tuesday, January 26
Kickstart your summit experience with dedicated workshop sessions designed to foster deeper discussion and stronger peer connections in a smaller, collaborative setting. Engage directly with fellow drug developers, translational scientists, clinical experts, and technology innovators as you work through shared challenges, exchange practical experiences, and explore solutions to key hurdles in muscular disorder drug development. With extended discussion time and highly focused content, the workshop day provides an ideal environment to build meaningful relationships before the main conference begins.
Organic Networking
Throughout the Muscular Disorders Drug Development Summit, attendees will benefit from continuous networking opportunities with experts spanning muscular dystrophy research, neuromuscular drug development, translational science, clinical development, biomarkers, and emerging therapeutics. From coffee breaks, lunches and informal conversations between presentations, every aspect of the event is designed to encourage collaboration, knowledge sharing, and new industry partnerships.